Keywords
How to Cite
Abstract
This thesis reviews a pragmatic framework for non-invasive diagnosis in metabolic-related steatohepatitis, focusing on test selection, sequencing, interpretation pitfalls, and pathway implementation across primary care and specialist settings.
References
1. Rinella M. E., Lazarus J. V., Ratziu V., Francque S. M., Sanyal A. J., Kanwal F., et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology, 2023, Vol. 78, No. 6, pp. 1966–1986. DOI: 10.1097/HEP.0000000000000520. PubMed+1
2. Berzigotti A., Tsochatzis E., Boursier J., Castera L., Cazzagon N., Friedrich-Rust M., et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis: 2021 update. Journal of Hepatology, 2021, Vol. 75, No. 3, pp. 659–689. DOI: 10.1016/j.jhep.2021.05.025. journal-of-hepatology.eu+1
3. Rinella M. E., Neuschwander-Tetri B. A., Siddiqui M. S., Abdelmalek M. F., Caldwell S., Barb D., et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology, 2023, Vol. 77, No. 5, pp. 1797–1835. DOI: 10.1097/HEP.0000000000000323. PubMed+1
4. Sterling R. K., Duarte-Rojo A., Patel K., Asrani S. K., Alsawas M., Dranoff J. A., et al. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. Hepatology, 2025, Vol. 81, No. 2, pp. 672–724. DOI: 10.1097/HEP.0000000000000843.